GMED Stock - Globus Medical, Inc.
Unlock GoAI Insights for GMED
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.52B | $1.57B | $1.02B | $958.10M | $789.04M |
| Gross Profit | $1.48B | $1.02B | $759.12M | $718.88M | $571.58M |
| Gross Margin | 58.9% | 65.1% | 74.2% | 75.0% | 72.4% |
| Operating Income | $165.99M | $133.14M | $227.95M | $171.95M | $111.43M |
| Net Income | $102.98M | $122.87M | $190.17M | $149.19M | $102.28M |
| Net Margin | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% |
| EPS | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Visit WebsiteEarnings History & Surprises
GMEDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 19, 2026 | $1.05 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.78 | $1.18 | +51.1% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.76 | $0.86 | +13.2% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.74 | $0.68 | -8.6% | ✗ MISS |
Q1 2025 | Feb 20, 2025 | $0.74 | $0.84 | +13.5% | ✓ BEAT |
Q4 2024 | Nov 5, 2024 | $0.65 | $0.83 | +28.3% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $0.68 | $0.75 | +10.3% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.57 | $0.72 | +27.0% | ✓ BEAT |
Q1 2024 | Feb 20, 2024 | $0.59 | $0.60 | +1.7% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.54 | $0.57 | +5.6% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.59 | $0.63 | +6.8% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.51 | $0.53 | +3.9% | ✓ BEAT |
Q1 2023 | Feb 21, 2023 | $0.56 | $0.59 | +5.4% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.52 | $0.50 | -3.8% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $0.53 | $0.56 | +5.7% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $0.47 | $0.42 | -10.6% | ✗ MISS |
Q1 2022 | Feb 17, 2022 | $0.48 | $0.49 | +2.1% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.45 | $0.50 | +11.1% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $0.45 | $0.56 | +24.4% | ✓ BEAT |
Q2 2021 | May 4, 2021 | $0.37 | $0.49 | +32.4% | ✓ BEAT |
Latest News
Frequently Asked Questions about GMED
What is GMED's current stock price?
What is the analyst price target for GMED?
What sector is Globus Medical, Inc. in?
What is GMED's market cap?
Does GMED pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GMED for comparison